Immunophenotyping using monoclonal antibodies (MAbs) has become a widespread tool in the scientific, as well as routine, pathological study of Non-Hodgkin's lymphoma (NHL). Larger studies have suggested that not only different histologically defined NHL subtypes, but also individual cases of a single NHL subtype, may vary considerably in the expression of leucocyte differentiation antigens (Schuurman et al., 1987) . The question, however, whether homo-or heterogenous phenotypes correspond to genetically monoclonal or non-monoclonal lymphomas, respectively, has not been investigated so far.
Richter's syndrome (RS), which is defined as the emergence of a large cell lymphoma (LCL) in the course of a chronic lymphocytic leukaemia (CLL) (Trump et al., 1980) , represents a unique condition for the study of this issue. While a number of clearly biclonal RS have been described (McDonnell et al., 1986; Ostrowski et al., 1989; Sklar et al., 1984; Van Dongen et al., 1984) , some cases seem to share a common clonal origin despite the heterogenous morphology of LCL and CLL tumors (Bertoli et al., 1987) . These cases thus offer an interesting opportunity to study the correlation between monoclonality and differentiation antigen expression. For a detailed analysis of the immunophenotype, a broad panel of MAbs can be used; these recognise lymphocyte surface antigens which have been extensively characterised by the International Leucocyte Typing Workshops (Knapp et al., 1989 (Arnold et al., 1983; Mayumi et al., 1982) .
We investigated the case of patient HK, a 47-year-old male, who presented in 1980 with enlarged lymph nodes, splenomegaly and a white blood cell count of 100,000 l-1. Histological (Trump et al., 1980 peroxidase method as described in detail elsewhere (Moller et al., 1989) . The results of three independent stainings performed on bone marrow, lymph node and kidney tissue samples, which are representative for all organs studied, are listed in Table I To test whether the observed differences in the expression of leucocyte differentiation antigens correlated with a biclonal lymphoma in patient HK, two independent strategies of probing for clonality were applied. Firstly, two monoclonal antibodies recognising idiotypic determinants on purified HK tumour immunoglobulin were manufactured using standard methods described previously in detail (Moldenhauer et al., 1983 aAntibodies produced in our laboratory. MAbs to differentiation antigens are described in 'Leucocyte Typing IV' (Knapp et al., 1989). tissues displayed an identical idiotype expression and immunoglobulin gene rearrangement. Given the extremely low probability for a common rearrangement with a shared idiotype in two independent tumours, these results clearly demonstrate a common clonal origin of both CLL and CBp tumour cells in the case presented. This is in accordance with three other published cases of clearly monoclonal RS (Bertoli et al., 1987; Michiels et al., 1989; Siegelman et al., 1985) . globulin gene heavy chain rearrangement, they displayed a distinct pattern of differentiation antigen expression. The phenotype of CLL cells with expression of pan-B markers CD19 and CD20, B-restricted markers CD22 and CD24 and expression of CD5 is in accordance with the data obtained in larger studies (Schuurman et al., 1987 (Adachi et al., 1989) and are thought to give rise mainly to indolent, slowly progressive lymphomas with nodular architecture (Yunis et al., 1987) . Translocations involving the c-myc oncogene together with immunoglobulin genes are found in the highly malignant Burkitt lymphomas and are associated with a high rate of cell proliferation (Taub et al., 1982 follicular lymphomas with a bc1-2 translocation may convert into highly malignant lymphomas upon further translocational events involving the c-myc gene (De Jong, 1988) . Therefore, we asked whether a translocation of c-myc into an immunoglobulin gene locus might have caused transformation of CLL cells to a highly malignant lymphoma with a high rate of proliferation. Owing to the lack of viable tumour cells from the clinical stage of RS, a cytogenetic analysis could not be done. Therefore, genomic DNA from CLL and 
